Rutgers’ RUCDR Infinite Biologics received an amended Emergency Use Authorization from the U.S. Food and Drug Administration for the first SARS-CoV-2 coronavirus test that will allow people to collect their own saliva at home and send to a lab for results.
San Diego-based Sorrento Therapeutics is teaming up with New York City-based Mount Sinai Health System to develop an antibody cocktail called COVI-SHIELD to treat COVID-19.
Multiple Studies Suggest COVID-19 Mortality Rate May Be Lower Than Expected
Coronavirus Cases, Coronavirus Disease 2019 (COVID-19), COVID-19 Testing, Iceland, Immune System, Lancet Infectious Diseases, Medical Journals, Mortality Rates, National Institutes of Health, New England Journal of Medicine, R&D, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Studies, World Health OrganizationAs the mortality figures for COVID-19 continued to rise, people are wondering where they will stop. The actual death toll for COVID-19 will not be calculable for some time, but there are early indications that the mortality rate may be significantly lower than calculations of deaths per confirmed cases lead one to believe.
A series of studies of the genomes of thousands of samples of the new coronavirus show that SARS-CoV-2 is mutating and evolving while adapting to human hosts.
Coronavirus Transmission: Where the Virus Goes in the Body and How SARS-CoV-2 is Spread
ACE2 (angiotensin-converting enzyme-2), Coronavirus Disease 2019 (COVID-19), Coronavirus Infections, Dr. Anthony Fauci (Director), Human Body, Medical Journals, National Institute of Allergy and Infectious Diseases (NIAID), R&D, Researchers, Science, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), The Lancet, World Health OrganizationA look at which parts of the body the novel coronavirus infects and how SARS-CoV-2 is transmitted from person to person.
Dr. Anthony Fauci – who has been considered one of the most trusted leaders tackling the COVID-19 pandemic in the United States – once again stressed that, as far as the evidence suggests, the novel coronavirus is naturally occurring and was not made in a laboratory.
The U.S. Food and Drug Administration green-lit Roche’s new Elecsys Anti-SARS-CoV-2 antibody test that will help determine whether or not people have been infected by the novel coronavirus that has swept across the globe and developed antibodies to the disease.
Research Roundup: Major Breakthrough in HIV Research and More
Australia, China, Coronavirus Disease 2019 (COVID-19), Drug Cocktails, Genes, Genetic Markers, Genomes, Germany, Herpes Simplex Virus, HIV, Immune Cells, Medical Journals, Mount Sinai, Neurodegenerative Diseases, New England Journal of Medicine, Nucleotides, R&D, RNA, San Francisco (UCSF), Science, Scientific studies, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), The Netherlands, Thrombosis Research, University of Alabama at Birmingham (UAB), University of Maryland Baltimore County, Walter and Eliza Hall InstituteA review of some recently published scientific studies, including researchers at the University of Maryland Baltimore County identifying a single nucleotide that controls two forms of the HIV virus’ RNA.
Pfizer and BioNTech Plan to Initiate U.S. COVID-19 Vaccine Trial
Antivirals, Business, Clinical Data, Clinical Trials, Collaborations, COVID-19 Vaccines, FDA, FDA/Regulatory, Immunogenicity, Messenger RNA (mRNA) Vaccines, R&D, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), The Wall Street JournalPfizer and Germany-based BioNTech, which are collaborating on a messenger RNA vaccine against SARS-CoV-2, plan to start testing in the United States once the Food and Drug Administration gives clearance.
Q1 Reports: Biogen, Merck and Other Biopharma Companies Note Ups and Downs Amid COVID-19 Pandemic
Biopharma, Biosimilars, Blockbusters, Business, China, Collaborations, Coronavirus Disease (COVID-19) Pandemic, Crop Sciences, Generics, Hemophilia, Messenger RNA (mRNA) Vaccines, Quarterly results, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), The Bill and Melinda Gates Foundation, Therapeutics, VaccinesNumerous major global biopharma companies reported first-quarter 2020 earnings. Typically, the COVID-19 pandemic has affected the companies, although not necessarily in a straightforward way. Many of the companies reported increased sales for the quarter as customers increased stockpiles and inventory in preparation for the pandemic, while other forms of sales and clinical trials were negatively impacted. Here’s a look.